Research/art/teacher profile of a person
Name and surname:
MUDr. Michal Mokáň, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Mokáň
I.2 - Name
Michal
I.3 - Degrees
MD, PhD
I.4 - Year of birth
1988
I.5 - Name of the workplace
Department of Internal Medicine I. JFM a UHM
I.6 - Address of the workplace
Kollárova 2, 036 59 Martin
I.7 - Position
Assistant
I.8 - E-mail address
michalmok5@gmail.com
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/20892
I.10 - Name of the study field in which a person works at the university
General Medicine

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
II.b - Year
2013
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava
II.b - Year
2017
II.c - Study field and programme
Internal Medicine
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Scientific Worker Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2013 - 2017
Assistant Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava 2017 -

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Specialisation in Endokrilology FM CU Bratislava 2019
Specialization in diabetology JFM Martin 2022

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Propedeutics of Internel Medicine 1,2 General Medicine I. + II. General Medicine
Internal Medicine 1 - 6 General Medicine I. + II. General Medicine
Internal Medicine 1 - 5 Dentistry, Dental Medicine I.+II. Dentistry, Dental Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
1
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Diploma Thesis Semminar 1 - 3 General Medicine I.+II. General Medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
111
VI.1.b - Over the last six years
73
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
34
VI.1.b - Over the last six years
27
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
95
VI.1.b - Over the last six years
91
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
69
VI.1.b - Over the last six years
68
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
0
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

ADC Nehaj, František (40%) - Sokol, Juraj (40%) - Ivanková, Jela (2%) - Mokáň, Michal (15%) - Kovář, František (1%) - Staško, Ján (1%) - Mokáň, Marián (1%): First Evidence: TRAP-InducedPlatelet Aggregation Is Reduced in Patients Receiving Xabans [elektronický dokument] In: Clinical and Applied Thrombosis /Hemostasis - Roč. 24, č. 6 (2018), s. 914-919. - ISSN 1076-0296 IF (JCR) 2018=1,846

2

ADC Sokol, Juraj (40%) - Nehaj, František (40%) - Ivanková, Jela (10%) - Mokáň, Michal (8%) - Mokáň, Marián (2%): First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation] In: Journal of Thrombosis and Thrombolysis. - Roč. 46, č. 3 (2018), s. 393-398 [print]. - ISSN 0929-5305 IF (JCR) 2018=2,941

3

ADC Bolek, Tomáš (52%) - Samoš, Matej [ (20%) - Stančiaková, Lucia (5%) - Ivanková, Jela (2%) - Škorňová, Ingrid (7%) - Staško, Ján (5%) - Galajda, Peter (2%) - Kubisz, Peter (2%) - Mokáň, Michal (5%): The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation In: American Journal of Therapeutics. - Roč. 26, č. 3 (2019), s. E308-E313. - ISSN 1075-2765 IF (JCR) 2019=1,955

4

ADC Nehaj, František (40%) - Sokol, Juraj (40%) - Ivanková, Jela (10%) - Mokáň, Michal (5%) - Mokáň, Marián (5%): Effect of Bisoprolol on the Level of Dabigatran In: American Journal of Therapeutics - Roč. 27, č. 2 (2020), s. E159-E164. - ISSN 1075-2765 IF (JCR) 2020=2.688

5

ADC Sokol, Juraj (20%) - Nehaj, František (20%) - Mokáň, Michal (20%) - Lisá, Lenka (20%) - Staško, Ján (20%): COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria[elektronický dokument] : a case report In: Medicine. - Roč. 100, č. 20 (2021), s. [1-4], art. no. 25456. - ISSN 0025-7974 IF (JCR) 2020 = 1.889 

VI.3 - The most significant research/artistic/other outputs over the last six years
1

ADC Nehaj, František (40%) - Sokol, Juraj (40%) - Ivanková, Jela (2%) - Mokáň, Michal (15%) - Kovář, František (1%) - Staško, Ján (1%) - Mokáň, Marián (1%): First Evidence: TRAP-InducedPlatelet Aggregation Is Reduced in Patients Receiving Xabans [elektronický dokument] In: Clinical and Applied Thrombosis /Hemostasis - Roč. 24, č. 6 (2018), s. 914-919. - ISSN 1076-0296 IF (JCR) 2018=1,846 

2

ADC Sokol, Juraj (40%) - Nehaj, František (40%) - Ivanková, Jela (10%) - Mokáň, Michal (8%) - Mokáň, Marián (2%): First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation] In: Journal of Thrombosis and Thrombolysis. - Roč. 46, č. 3 (2018), s. 393-398 [print]. - ISSN 0929-5305 IF (JCR) 2018=2,941

3

ADC Bolek, Tomáš (52%) - Samoš, Matej [ (20%) - Stančiaková, Lucia (5%) - Ivanková, Jela (2%) - Škorňová, Ingrid (7%) - Staško, Ján (5%) - Galajda, Peter (2%) - Kubisz, Peter (2%) - Mokáň, Michal (5%): The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation In: American Journal of Therapeutics. - Roč. 26, č. 3 (2019), s. E308-E313. - ISSN 1075-2765 IF (JCR) 2019=1,955 

4

ADC Nehaj, František (40%) - Sokol, Juraj (40%) - Ivanková, Jela (10%) - Mokáň, Michal (5%) - Mokáň, Marián (5%): Effect of Bisoprolol on the Level of Dabigatran In: American Journal of Therapeutics - Roč. 27, č. 2 (2020), s. E159-E164. - ISSN 1075-2765 IF (JCR) 2020=2.688

5

ADC Sokol, Juraj (20%) - Nehaj, František (20%) - Mokáň, Michal (20%) - Lisá, Lenka (20%) - Staško, Ján (20%): COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria[elektronický dokument] : a case report In: Medicine. - Roč. 100, č. 20 (2021), s. [1-4], art. no. 25456. - ISSN 0025-7974 IF (JCR) 2020 = 1.889

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

ADC Nehaj, František (40%) - Sokol, Juraj (40%) - Ivanková, Jela (2%) - Mokáň, Michal (15%) - Kovář, František (1%) - Staško, Ján (1%) - Mokáň, Marián (1%): First Evidence: TRAP-InducedPlatelet Aggregation Is Reduced in Patients Receiving Xabans [elektronický dokument] In: Clinical and Applied Thrombosis /Hemostasis - Roč. 24, č. 6 (2018), s. 914-919. - ISSN 1076-0296 IF (JCR) 2018=1,846


2

ADC Sokol, Juraj (40%) - Nehaj, František (40%) - Ivanková, Jela (10%) - Mokáň, Michal (8%) - Mokáň, Marián (2%): First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation] In: Journal of Thrombosis and Thrombolysis. - Roč. 46, č. 3 (2018), s. 393-398 [print]. - ISSN 0929-5305 IF (JCR) 2018=2,941


3

ADC Bolek, Tomáš (52%) - Samoš, Matej [ (20%) - Stančiaková, Lucia (5%) - Ivanková, Jela (2%) - Škorňová, Ingrid (7%) - Staško, Ján (5%) - Galajda, Peter (2%) - Kubisz, Peter (2%) - Mokáň, Michal (5%): The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation In: American Journal of Therapeutics. - Roč. 26, č. 3 (2019), s. E308-E313. - ISSN 1075-2765 IF (JCR) 2019=1,955


4

ADC Nehaj, František (40%) - Sokol, Juraj (40%) - Ivanková, Jela (10%) - Mokáň, Michal (5%) - Mokáň, Marián (5%): Effect of Bisoprolol on the Level of Dabigatran In: American Journal of Therapeutics - Roč. 27, č. 2 (2020), s. E159-E164. - ISSN 1075-2765 IF (JCR) 2020=2.688


5

ADC Sokol, Juraj (20%) - Nehaj, František (20%) - Mokáň, Michal (20%) - Lisá, Lenka (20%) - Staško, Ján (20%): COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria[elektronický dokument] : a case report In: Medicine. - Roč. 100, č. 20 (2021), s. [1-4], art. no. 25456. - ISSN 0025-7974 IF (JCR) 2020 = 1.889


VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

APVV-17-0054 (2018 – 2022) New oral anticoagulans in prevention of the most serious cardiovascular diseases, their effect to platelets, drug interactions, safety and treatment possibilities also in oncologic patients. Principal Investigator.


VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2025-02-20